News, Analysis & Insights on Nutrition, Supplements, and Health
A new survey by the UK's Food Commission finds that the food industry has done little to tackle the problem of salt in our diets - in some cases, levels are hardly any lower than they were in the 70's, despite repeated promises from manufacturers.
Vitamin D rather than calcium intake is important in protecting post-menopausal women from fractures associated with osteoporosis, US researchers confirm in the February issue of the American Journal of Clinical Nutrition.
Researchers in the Netherlands studying people with a genetically determined, reduced breakdown of the amino acid homocysteine, may have found further proof of the connection between folic acid deficiency and the risk of heart disease.
AAC Consulting Group, the regulatory consulting subsidiary of contract research organisation Kendle International, has signed an agreement with two toxicologists to further expand its services to the food and dietary supplement industries.
A botanicals research project has been launched by ingredients supplier Unigen Pharmaceuticals and the consultants Botanical Liaisons to discover new plants that could be used in natural medicines.
News to delight dairy manufacturers and dismay opponents to genetically modified foods arrived this week with publication of a new study that reveals protein-rich milk from not only cloned but also genetically modified cows could cut cheese-making...
The health food and sports nutrition business of Novartis, now called Nutrition & Santé, saw a small rise in sales for fiscal 2002. The Swiss pharma group is trying to grow the unit ahead of its planned divestment.
Red-clover derived isoflavones may help prevent the progression of prostate cancer in patients by inducing cell death in the cancer tumours, report Australian researchers, who say their small study could explain the geographical incidence of the disease.
US flavours and fragrance giant International Flavors & Fragrances saw fourth quarter 2002 sales rise 5 per cent to $424.3 million (€391m) from $405.6 million for the same period in 2001, despite weak economic conditions in Latin America.
Colorado-based nutraceuticals company NutraStar said this week it has been awarded a US patent for its stabilized bran treatment for inflammation and pain in mammals.